After admitting mistake, AstraZeneca faces difficult questions about its coronavirus vaccine
Since unveiling the preliminary results, AstraZeneca has acknowledged a key mistake in the vaccine dosage received by some study participants, adding to questions about whether the vaccine ’s apparently spectacular efficacy will hold up under additional testing.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: AstraZeneca | Biotechnology | Coronavirus | COVID-19 | Pharmaceuticals | Study | Vaccines